Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
SGLT2 inhibitors as first-line therapy in type 2 diabetes
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 박정환 | - |
| dc.date.accessioned | 2024-12-05T19:30:30Z | - |
| dc.date.available | 2024-12-05T19:30:30Z | - |
| dc.date.issued | 2023-04-06 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/201304 | - |
| dc.title | SGLT2 inhibitors as first-line therapy in type 2 diabetes | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 2023 대한내분비학회 춘계학술대회 및 학연산 심포지엄 | - |
| dc.citation.conferencePlace | 롯데호텔 부산 | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Park, Jung Hwan
- 서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)